AADX shorts rebuild ahead of November earnings

Applied Aerospace & Defense heads into its November 11 results with short sellers rebuilding positions, analysts trimming targets, and a bruising month behind it.

Short interest has climbed sharply over the past four weeks. Estimated shares short rose nearly 20% on the week and are up 16% over the past month, now running at roughly 8.4 million shares. That build has come even as the stock dropped 15% in October, closing Tuesday at $10.74, suggesting shorts are not simply riding momentum but actively adding conviction. The ORTEX short score has drifted up to 71.8, its highest reading in the trailing two weeks. Availability in the lending market has tightened meaningfully too: the share of the pool still available to borrow has fallen to 46%, down from above 95% at the end of September and approaching the 52-week low of 35.8% touched on October 19. That is not a fully squeezed borrow market, but it is tighter than it was, and borrowing costs have risen 37% over the past month to 1.29%. Options positioning remains tilted toward calls: the put/call ratio is 0.49, only marginally above its 20-day average of 0.47 and well below the 52-week high of 1.01. The options market, unlike the short book, is not yet pricing in much downside.

Analysts are a more complicated story. Targets have come down in a cluster over October, the clearest signal that professional conviction has wobbled. RBC Capital's Ken Herbert trimmed his target today to $18 from $21, maintaining an Outperform rating. Morgan Stanley's Kristine Liwag cut hers to $16 from $24 last week, holding at Equal-Weight. Those two moves, coming within ten days of each other from a bellwether and a major bank respectively, tell a coherent story: the Street still leans positive on the business but has reset its valuation anchor lower. The consensus mean target is $22.88, roughly double the current price, though that figure includes initiations from late June at $24 and a Guggenheim Buy at $30 from September, both set when the stock was trading much higher. The bull case rests on an $1.06 billion backlog, 88% IP-enabled revenue, 86% sole-source exposure, and mid-20% adj. EBITDA margins, with mid-teens organic growth expected through 2028 driven by missile/munition ramp and space launch. The bear case centres on whether the second half margin ramp embedded in 2026 guidance actually materialises, with the August earnings print having posted 21.8% EBITDA margins while leaving annual guidance unchanged. Fixed-price contracts, specialty-material inflation, and roughly $53 million of seller-related cash payments are the key drags the bears point to.

On ownership, the structure is unusual. AA&D Holdings, LP holds 73.5% of shares outstanding, a stake disclosed via Schedule 13G in August, meaning it is classified as a passive 5%-plus holder rather than an activist. That concentration leaves a comparatively thin public float, which amplifies the impact of the short-building seen this month. Among institutional holders beyond the controlling entity, most positions were new as of the last reported quarter, including AllianceBernstein, Temasek, MFS, Baron Capital, and T. Rowe Price, all of which appear to have initiated positions in the June to August window at prices well above today's level.

The Russell 2000 addition in September, which required an estimated $96 million of index tracker buying over roughly 5.7 days of normal volume, is already behind the stock. ORTEX puts the probability of subsequent addition to the MSCI USA IMI, MSCI USA Small, MSCI World IMI, and MSCI World Small indices at 27% each for the November quarterly review, with announcement expected on November 11 (the same day as earnings) and a trade date of November 30. Those are forecasts, not announcements, and at 27% they are far from base case. The coincidence of the MSCI announcement date with the earnings release means November 11 carries two distinct potential catalysts.

The last earnings print on August 12 saw the stock fall 8.7% on the day and 16.1% over the following five sessions. What to watch on November 11 is whether the 2H26 margin progression matches what guidance requires, and whether any update to the 2027 program outlook, particularly on the MV-75 program, shifts the narrative on structural earnings power.